Mitesco (Mitesco) Risk Assessment

View and export this data going back to 2011. Start your Free Trial

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Mitesco is: No Data: Cannot be evaluated.

Competitive Comparison

For the Health Information Services subindustry, Mitesco's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mitesco Risk Assessment Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Mitesco's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Mitesco's Risk Assessment falls into.

Mitesco (OTCPK:MITI) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Mitesco Risk Assessment Related Terms

Thank you for viewing the detailed overview of Mitesco's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Mitesco (Mitesco) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mitesco Inc (OTCPK:MITI) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

18202 Minnetonka Boulevard, Suite 100, Deephaven, MN, USA, 55391

Website

https://www.mitescoinc.com

Mitesco Inc is a development stage company who acquires and implements technologies and services to improve the quality of care, reduce cost, and enhance consumer convenience. It is focused on developing a portfolio of companies that provide healthcare technology solutions and the team is adept at deal structures supportive of long term organizational value.

Executives

Lonnie Allen Plunk	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lawrence M. Diamond	director	7535 EAST HAMPDEN AVENUE, SUITE 400, DENVER CO 80231
Phillip J Keller	officer: Chief Financial Officer	2323 RING ROAD, ELIZABETHTOWN KY 42701
Sheila Schweitzer	director	1200 CAROLINA CIRCLE, VERO BEACH FL 62962
Ingrid Jenny Lindstrom	officer: Chief Legal Officer	1100 WILLS PLACE, GOLDEN VALLEY MN 55422
Juan Carlos Iturregui	director	5606 ALBIA RD., BETHESDA MD 20816
Faraz Naqvi	director	3001 HEARTHSTONE DRIVE, FORT COLLINS CO 80528
Thomas Brodmerkel	director	7535 EAST HAMPDEN AVENUE, STE. 400, DENVER CO 80231
Julie R. Smith	director	7535 EAST HAMPDEN AVENUE, SUITE 400, DENVER CO 80231
Ron Riewold	officer: CHAIRMAN	37 NORTH ORANGE AVE, STE 500, ORLANDO FL 32801
Douglas Cole	director	C/O AMERICAN BATTERY METALS CORP, 930 TAHOE BLVD, STE 802-16, INCLINE VILLAGE NV 89451
James Philip Crone	director, officer: Pres, Interim CFO, Sec, Dir	1355 PEACHTREE STREET, SUITE 1150, ATLANTA GA 30309
Morton James E Iii	officer: President	549 VIKINGS LANE, ATLANTIC BEACH FL 32233
Deluca Louis George Jr	officer: C.O.O.	194 EDWARDS DR, MABLETON GA 30126
Thomas W. Burnell	officer: President and CEO	1355 PEACHTREE STREET, SUITE 1150, ATLANTA GA 30309